In Focus channel feed – Endpoints News

In Focus channel feed

The coronavirus vaccine that the world forgot could still help save it

4 years ago

As Bayer, Novartis stack up their radiopharmaceutical data at #ESMO21, a key debate takes shape

4 years ago

Inside the quixotic 30-year quest that gave us the Covid-19 treatments, vaccines and could unlock vaccinology’s new holy grail

4 years ago

'The consummate mentor': Bill Clinton, Jim Wilson and others reflect on Tachi Yamada's life and legacy

4 years ago

In CureVac's failure, a possible verdict on the past (and future) of mRNA vaccines

4 years ago

How one startup foretold the neuroscience renaissance after '50 years of shitshow'

4 years ago

On the hunt for the next Moderna, investors have pumped 'platform plays' with cash. Can anything slow the runaway train?

5 years ago

FDA's controversial Aduhelm decision leaves ALS patients feeling spurned

5 years ago

Whatever the FDA decides on aducanumab, Alzheimer's research is finally, mostly, kind of moving beyond the amyloid hypothesis

5 years ago

A simple patient survey revolutionized ALS drug development in the 1990s. Its creator says it may be time for an upgrade

5 years ago

Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?

5 years ago

Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'?

5 years ago

As fears mount over J&J and AstraZeneca, Novavax enters a shaky spotlight

5 years ago

Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery

5 years ago

'Part of recovery is awareness': Pandemic casts harsh spotlight on industry-wide lack of diversity in clinical trials

5 years ago

David Liu has a new big idea: proteome editing. It could one day shred tau, RAS and some of the worst disease-causing proteins

5 years ago

Biopharma's success rate in bringing drugs to market has long been abysmal. Can new tools help rewrite that troubled past?

5 years ago

Exclusive: After four decades, one researcher's radical HIV cure finally gets its shot

5 years ago

After 3 deaths rock the field, gene therapy researchers contemplate AAV's future

5 years ago

Can a new CRISPR technique unlock the secrets of how cancer spreads?

5 years ago

They thought their gene therapy failed. Instead, it spawned a medical mystery

5 years ago

As the curtain closes on the Trump presidency, biotech wrestles with its future in a divided America

5 years ago

Can a darkhorse synthetic biology Covid-19 vaccine one-up the frontunners? The Gates Foundation, Amgen bet 'yes'

5 years ago

After falling behind the leaders, dissed by some experts, biotech showman Patrick Soon-Shiong finally gets his Covid-19 vaccine ready for a trial. But can it live up to the hype?

5 years ago

First page Previous page 4 5 678 Next page Last page